Last reviewed · How we verify
NCT05442398
Celiac Disease and Diabetes Mellitus
trial in Celiac Disease in Children in 41 participants. Completed in 2 August 2024.
31 December 2023
Quick facts
| Lead sponsor | Mohamed Salah Ahmed Ali |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 41 |
| Start date | 1 July 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 2 August 2024 |
| Sites | 1 location across Egypt |
Conditions studied
- Celiac Disease in Children — all drugs for Celiac Disease in Children →
Sponsor
Mohamed Salah Ahmed Ali
Who can join
Adults 1 to 18, any sex, with Celiac Disease in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to detect Celiac Disease among suspected patients with Type 1 Diabetes Mellitus who admitted to Assiut University Children's Hospital during one year duration
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05442398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Celiac Disease in Children
Currently open trials in the same condition.
- NCT06849622 — Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease · NA · recruiting
- NCT06568263 — Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife) · recruiting
- NCT06364735 — Entities and Variables Related to Catch-up Growth · recruiting
- NCT04806620 — Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research · recruiting
- NCT05209568 — Immune Responses to Gluten · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05442398 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mohamed Salah Ahmed Ali
- Last refreshed: 5 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05442398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing